Skip to main content

DGE 7th Decentralized & Hybrid Clinical Trials Summit to Expand Trial Accessibility and Diversity

DGE invites Clinical Innovation and Development experts, Patient Recruitment specialists, and Clinical Safety/Regulatory Affairs officers, to attend the 7th Decentralized & Hybrid Clinical Trials Summit, to be held in Philadelphia, PA, May 10-11, 2023.

Decentralized and hybrid clinical trials remove geographic hurdles and increase patient participation rates and diversity – as long as the teams are aptly trained and have the right…

Read More>>

The 7th Decentralized & Hybrid Clinical Trials Summit is the industry’s most reliable conference for

To learn more, please visit https://ibn.fm/IBbV1

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
Editor@InvestorWire.com

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.